Novel Outcome Measures for Clinical Trials in Cystic Fibrosis

Cystic fibrosis (CF) is a common inherited condition caused by mutations in the gene encoding the CF transmembrane regulator protein. With increased understanding of the molecular mechanisms underlying CF and the development of new therapies there comes the need to develop new outcome measures to as...

Descripción completa

Detalles Bibliográficos
Autores principales: Tiddens, Harm AWM, Puderbach, Michael, Venegas, Jose G, Ratjen, Felix, Donaldson, Scott H, Davis, Stephanie D, Rowe, Steven M, Sagel, Scott D, Higgins, Mark, Waltz, David A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2015
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4365726/
https://www.ncbi.nlm.nih.gov/pubmed/25641878
http://dx.doi.org/10.1002/ppul.23146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4365726/
https://www.ncbi.nlm.nih.gov/pubmed/25641878
http://dx.doi.org/10.1002/ppul.23146

Ejemplares similares